• 2179 Citations
  • 23 Scopus h-Index
1982 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1982 2019

  • 2179 Citations
  • 23 Scopus h-Index
  • 59 Article
  • 1 Editorial
Filter
Article
2019

A Case of Donor-Transmitted Non-Small Cell Lung Cancer After Liver Transplantation: An Unwelcome Guest

Sonbol, M. B., Halling, K. C., Douglas, D. D. & Ross, H. J., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

Liver Neoplasms
Non-Small Cell Lung Carcinoma
Liver Transplantation
Tissue Donors
Neoplasms
5 Citations (Scopus)

Expert Consensus Document on Pulmonary Metastasectomy

Handy, J. R., Bremner, R. M., Crocenzi, T. S., Detterbeck, F. C., Fernando, H. C., Fidias, P. M., Firestone, S., Johnstone, C. A., Lanuti, M., Litle, V. R., Kesler, K. A., Mitchell, J. D., Pass, H. I., Ross, H. J. & Varghese, T. K., Feb 1 2019, In : Annals of Thoracic Surgery. 107, 2, p. 631-649 19 p.

Research output: Contribution to journalArticle

Metastasectomy
Lung
1 Citation (Scopus)

Small-cell Lung Cancer in Very Elderly (≥ 80 Years) Patients

Schild, S. E., Zhao, L., Wampfler, J. A., Daniels, T. B., Sio, T., Ross, H. J., Paripati, H., Marks, R. S., Yi, J., Liu, H., He, Y. & Yang, P., Jan 1 2019, In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Survival
Therapeutics
Geriatric Assessment
Drug Therapy
2018
2 Citations (Scopus)
Paclitaxel
Adenocarcinoma
Programmed Cell Death 1 Receptor
Drug Therapy
Esophagogastric Junction
2017
1 Citation (Scopus)

A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

Sanborn, R. E., Ross, H. J., Aung, S., Acheson, A., Moudgil, T., Puri, S., Hilton, T., Fisher, B., Coffey, T., Paustian, C., Neuberger, M., Walker, E., Hu, H. M., Urba, W. J. & Fox, B. A., Dec 19 2017, In : Journal for ImmunoTherapy of Cancer. 5, 1, 103.

Research output: Contribution to journalArticle

docetaxel
Non-Small Cell Lung Carcinoma
Vaccines
Neoplasms
Interleukin-5
2 Citations (Scopus)

Incidence of brain metastasis from esophageal cancer

Welch, G., Ross, H. J., Patel, N. P., Jaroszewski, D. E., Fleischer, D. E., Rule, W. G., Paripati, H., Ramirez, F. C. & Ashman, J. B., Sep 1 2017, In : Diseases of the Esophagus. 30, 9, p. 1-6 6 p.

Research output: Contribution to journalArticle

Esophageal Neoplasms
Neoplasm Metastasis
Incidence
Brain
Survival
6 Citations (Scopus)

Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non–Small Cell Lung Cancer: NCCTG N0028 (Alliance)

Mayo Clinic, North Central Cancer Treatment Group, Apr 1 2017, In : Journal of Thoracic Oncology. 12, 4, p. 697-703 7 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Radiation
Drug Therapy
Radiotherapy
Maximum Tolerated Dose
2016
6 Citations (Scopus)

A randomized, controlled study of an online intervention to promote job satisfaction and well-being among physicians

Dyrbye, L. L., West, C. P., Richards, M. L., Ross, H. J., Satele, D. & Shanafelt, T. D., Sep 1 2016, In : Burnout Research. 3, 3, p. 69-75 7 p.

Research output: Contribution to journalArticle

Job Satisfaction
Quality of Life
Physicians
Fatigue
Depression
11 Citations (Scopus)

A randomized phase II study of linsitinib (OSI-906) versus Topotecan in patients with relapsed small-cell lung cancer

Chiappori, A. A., Otterson, G. A., Dowlati, A., Traynor, A. M., Horn, L., Owonikoko, T. K., Ross, H. J., Hann, C. L., Hejleh, T. A., Nieva, J., Zhao, X., Schell, M. & Sullivan, D. M., Oct 1 2016, In : Oncologist. 21, 10, p. 1163-1164 2 p.

Research output: Contribution to journalArticle

Topotecan
Small Cell Lung Carcinoma
Confidence Intervals
Growth Factor Receptors
Thrombocytopenia
5 Citations (Scopus)

Incidence and impact of postoperative atrial fibrillation after minimally invasive esophagectomy

Day, R. W., Jaroszewski, D., Chang, Y. H. H., Ross, H. J., Paripati, H., Ashman, J. B., Rule, W. G. & Harold, K. L., Aug 1 2016, In : Diseases of the Esophagus. 29, 6, p. 583-588 6 p.

Research output: Contribution to journalArticle

Esophagectomy
Atrial Fibrillation
Incidence
Mortality
Anastomotic Leak
14 Citations (Scopus)

Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic

Curtis, K. K., Ross, H. J., Garrett, A. L., Jizba, T. A., Patel, A. B., Patel, S. H., Wong, W. W., Halyard, M. Y., Ko, S. J., Kosiorek, H. E. & Foote, R. L., Apr 9 2016, In : Radiation Oncology. 11, 1, 55.

Research output: Contribution to journalArticle

Survival
Recurrence
Carcinoma, squamous cell of head and neck
Re-Irradiation
Osteoradionecrosis
2015
8 Citations (Scopus)

A new scoring system for predicting survival in patients with non-small cell lung cancer

Schild, S. E., Tan, A. D., Wampfler, J. A., Ross, H. J., Yang, P. & Sloan, J. A., Sep 1 2015, In : Cancer Medicine. 4, 9, p. 1334-1343 10 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Survival
Multivariate Analysis
Smoking Cessation
Proportional Hazards Models
9 Citations (Scopus)

Past approaches and future directions for targeting tumor hypoxia in squamous cell carcinomas of the head and neck

Curtis, K. K., Wong, W. W. & Ross, H. J., Nov 4 2015, (Accepted/In press) In : Critical Reviews in Oncology/Hematology.

Research output: Contribution to journalArticle

Carcinoma, squamous cell of head and neck
Direction compound
Tumor Hypoxia
Radiation
Literature
76 Citations (Scopus)

PRONOUNCE: Randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancer

Zinner, R. G., Obasaju, C. K., Spigel, D. R., Weaver, R. W., Beck, J. T., Waterhouse, D. M., Modiano, M. R., Hrinczenko, B., Nikolinakos, P. G., Liu, J., Koustenis, A. G., Winfree, K. B., Melemed, S. A., Guba, S. C., Ortuzar, W. I., Desaiah, D., Treat, J. A., Govindan, R. & Ross, H. J., Jan 1 2015, In : Journal of Thoracic Oncology. 10, 1, p. 134-142 9 p.

Research output: Contribution to journalArticle

Pemetrexed
Carboplatin
Paclitaxel
Non-Small Cell Lung Carcinoma
Maintenance
2014
8 Citations (Scopus)

NCCTG N0821 (Alliance): A phase ii first-line study of pemetrexed, carboplatin, and bevacizumab in elderly patients with advanced nonsquamous non-small-cell lung cancer with good performance status

Dy, G. K., Molina, J. R., Qi, Y., Ansari, R., Thomas, S., Ross, H. J., Soori, G., Anderson, D., Christine Aubry, M., Meyers, J., Adjei, A. A., Mandrekar, S. J. & Adjei, A., 2014, In : Journal of Thoracic Oncology. 9, 8, p. 1146-1153 8 p.

Research output: Contribution to journalArticle

Pemetrexed
Carboplatin
Non-Small Cell Lung Carcinoma
Quality of Life
Confidence Intervals
61 Citations (Scopus)

Obesity and risk of esophageal adenocarcinoma and barrett's esophagus: A mendelian randomization study

Mayo Clinic Esophageal Adenocarcinoma and Barrett's Esophagus Registry Consortium, Ashman, J. B., Bouras, E. P., Cassivi, S. D., Crowell, M. D., De Groen, P., DiBaise, J. K., Erlichman, C., Fitch, T. R., Fleischer, D. E., Foxx-Orenstein, A. E., Halling, K. C., Houghton, L. A., Keaveny, A. P., Locke, G. R. & Martenson, J. A., Nov 1 2014, In : Journal of the National Cancer Institute. 106, 11, dju252.

Research output: Contribution to journalArticle

Barrett Esophagus
Random Allocation
Body Mass Index
Obesity
Adenocarcinoma
21 Citations (Scopus)

Outcomes of minimally invasive esophagectomy in esophageal cancer after neoadjuvant chemoradiotherapy

Warner, S., Chang, Y. H., Paripati, H., Ross, H. J., Ashman, J., Harold, K., Day, R., Stucky, C. C., Rule, W. & Jaroszewski, D., Feb 2014, In : Annals of Thoracic Surgery. 97, 2, p. 439-445 7 p.

Research output: Contribution to journalArticle

Esophagectomy
Chemoradiotherapy
Esophageal Neoplasms
Neoadjuvant Therapy
Morbidity
29 Citations (Scopus)

Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer

GEM017 Investigatorsa, 2014, In : Lung Cancer. 85, 3, p. 420-428 9 p.

Research output: Contribution to journalArticle

Mesylates
Carboplatin
Small Cell Lung Carcinoma
Etoposide
Confidence Intervals
12 Citations (Scopus)

Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma

Krug, L. M., Wozniak, A. J., Kindler, H. L., Feld, R., Koczywas, M., Morero, J. L., Rodriguez, C. P., Ross, H. J., Bauman, J. E., Orlov, S. V., Ruckdeschel, J. C., Mita, A. C., Fein, L., He, X., Hall, R., Kawabe, T. & Sharma, S., 2014, In : Lung Cancer. 85, 3, p. 429-434 6 p.

Research output: Contribution to journalArticle

Pemetrexed
Cisplatin
Disease-Free Survival
Drug Therapy
Clinical Trials, Phase I
2013
32 Citations (Scopus)

A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North central cancer treatment group study N0528

Adjei, A., Dy, G. K., Mandrekar, S. J., Nelson, G. D., Meyers, J. P., Adjei, A. A., Ross, H. J., Ansari, R. H., Lyss, A. P., Stella, P. J., Schild, S. E. & Molina, J. R., Jan 2013, In : Journal of Thoracic Oncology. 8, 1, p. 79-88 10 p.

Research output: Contribution to journalArticle

gemcitabine
Carboplatin
Non-Small Cell Lung Carcinoma
Neoplasms
Survival
2012
34 Citations (Scopus)

A phase i trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer

Chiappori, A. A., Schreeder, M. T., Moezi, M. M., Stephenson, J. J., Blakely, J., Salgia, R., Chu, Q. S., Ross, H. J., Subramaniam, D. S., Schnyder, J. & Berger, M. S., Feb 28 2012, In : British Journal of Cancer. 106, 5, p. 839-845 7 p.

Research output: Contribution to journalArticle

Carboplatin
Small Cell Lung Carcinoma
Etoposide
Maximum Tolerated Dose
Central Nervous System
9 Citations (Scopus)

Multimodality therapy improves survival in elderly patients with locally advanced non-small cell lung cancer-A retrospective analysis

Paripati, H., Karlin, N. J., Schild, S. E., Vora, S. A., Dueck, A. & Ross, H. J., Apr 2012, In : Journal of Geriatric Oncology. 3, 2, p. 104-110 7 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Survival
Therapeutics
Age Groups
Combined Modality Therapy
48 Citations (Scopus)

Prophylactic cranial irradiation in small-cell lung cancer: Findings from a North Central Cancer Treatment Group Pooled Analysis

Schild, S. E., Foster, N. R., Meyers, J. P., Ross, H. J., Stella, P. J., Garces, Y. I., Olivier, K. R., Molina, J. R., Past, L. R. & Adjei, A., Nov 2012, In : Annals of Oncology. 23, 11, p. 2919-2924 6 p., mds123.

Research output: Contribution to journalArticle

Cranial Irradiation
Small Cell Lung Carcinoma
Neoplasms
Therapeutics
Dose Fractionation
2011
17 Citations (Scopus)

An early experience using the technique of transoral OrVil EEA stapler for minimally invasive transthoracic esophagectomy

Jaroszewski, D. E., Williams, D. G., Fleischer, D. E., Ross, H. J., Romero, Y. & Harold, K. L., Nov 2011, In : Annals of Thoracic Surgery. 92, 5, p. 1862-1869 8 p.

Research output: Contribution to journalArticle

Esophagectomy
Pathologic Constriction
Anastomotic Leak
Radiotherapy
Operative Time
2010
1 Citation (Scopus)

Paraneoplastic polymyositis associated with mesothelioma: A brief report

Schuster, S. R., Burnette, B. L., de Petr, G., Harmon, C. E., Camoriano, J. K. & Ross, H. J., Apr 2010, In : Community Oncology. 7, 4, p. 178-180 3 p.

Research output: Contribution to journalArticle

Polymyositis
Myositis
Mesothelioma
Paraneoplastic Syndromes
Asbestos
81 Citations (Scopus)

Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer

Ross, H. J., Blumenschein, G. R., Aisner, J., Damjanov, N., Dowlati, A., Garst, J., Rigas, J. R., Smylie, M., Hassani, H., Allen, K. E., Leopold, L., Zaks, T. Z. & Shepherd, F. A., Mar 15 2010, In : Clinical Cancer Research. 16, 6, p. 1938-1949 12 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Multicenter Studies
Appointments and Schedules
Epidermal Growth Factor Receptor
Mutation
12 Citations (Scopus)

Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancer

Movsas, B., Langer, C. J., Ross, H. J., Wang, L., Jotte, R. M., Feigenberg, S., Xu, F., Huang, C. H., Monberg, M. J. & Obasaju, C. K., May 2010, In : Journal of Thoracic Oncology. 5, 5, p. 673-679 7 p.

Research output: Contribution to journalArticle

docetaxel
gemcitabine
Etoposide
Non-Small Cell Lung Carcinoma
Cisplatin
2009
4 Citations (Scopus)
Consolidation Chemotherapy
Topotecan
Combined Modality Therapy
consolidation
chemotherapy
53 Citations (Scopus)

Single-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: Prognostic factors and treatment selection based on two large randomized clinical trials

Lilenbaum, R., Villaflor, V. M., Langer, C., O'Byrne, K., O'Brien, M., Ross, H. J., Socinski, M., Oldham, F. B., Sandilac, L., Singer, J. W. & Bonomi, P., Jul 2009, In : Journal of Thoracic Oncology. 4, 7, p. 869-874 6 p.

Research output: Contribution to journalArticle

Combination Drug Therapy
Non-Small Cell Lung Carcinoma
Randomized Controlled Trials
Therapeutics
gemcitabine
2008
6 Citations (Scopus)

Biphasic pulmonary blastoma with germ cell differentiation in a 36-year-old man

Archie, P. H., Beasley, M. B. & Ross, H. J., Oct 2008, In : Journal of Thoracic Oncology. 3, 10, p. 1185-1187 3 p.

Research output: Contribution to journalArticle

Pulmonary Blastoma
Germ Cells
Cell Differentiation
Embryonal Carcinoma
Neoplasms
141 Citations (Scopus)

Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer

Langer, C. J., O'Byrne, K. J., Socinski, M. A., Mikhailov, S. M., Leśniewski-Kmak, K., Smakal, M., Ciuleanu, T. E., Orlov, S. V., Dediu, M., Heigener, D., Eisenfeld, A. J., Sandalic, L., Oldham, F. B., Singer, J. W. & Ross, H. J., Jun 2008, In : Journal of Thoracic Oncology. 3, 6, p. 623-630 8 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Non-Small Cell Lung Carcinoma
Drug Therapy
Premedication
118 Citations (Scopus)

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

Paz-Ares, L., Ross, H. J., O'Brien, M., Riviere, A., Gatzemeier, U., Von Pawel, J., Kaukel, E., Freitag, L., Digel, W., Bischoff, H., García-Campelo, R., Iannotti, N., Reiterer, P., Bover, I., Prendiville, J., Eisenfeld, A. J., Oldham, F. B., Bandstra, B., Singer, J. W. & Bonomi, P., May 20 2008, In : British Journal of Cancer. 98, 10, p. 1608-1613 6 p.

Research output: Contribution to journalArticle

docetaxel
Non-Small Cell Lung Carcinoma
Therapeutics
Febrile Neutropenia
Alopecia
2 Citations (Scopus)

Selective dose escalation of chemoradiotherapy for locally advanced esophageal cancer

Seung, S. K., Smith, J. W. & Ross, H. J., 2008, In : Diseases of the Esophagus. 21, 7, p. 589-595 7 p.

Research output: Contribution to journalArticle

Chemoradiotherapy
Esophageal Neoplasms
Amifostine
Esophageal Stenosis
Survival
2007
62 Citations (Scopus)

A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer

Gandhi, L., Harding, M. W., Neubauer, M., Langer, C. J., Moore, M., Ross, H. J., Johnson, B. E. & Lynch, T. J., Mar 1 2007, In : Cancer. 109, 5, p. 924-932 9 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Multiple Drug Resistance
Vincristine
Doxorubicin
Safety
190 Citations (Scopus)

Randomized Phase II study of gemcitabine plus cisplatin, with or without cetuximab, as first-line therapy for patients with advanced or metastatic non-small-cell lung cancer

Butts, C. A., Bodkin, D., Middleman, E. L., Englund, C. W., Ellison, D., Alam, Y., Kreisman, H., Graze, P., Maher, J., Ross, H. J., Ellis, P. M., McNulty, W., Kaplan, E., Pautret, V., Weber, M. R. & Shepherd, F. A., Dec 20 2007, In : Journal of Clinical Oncology. 25, 36, p. 5777-5784 8 p.

Research output: Contribution to journalArticle

gemcitabine
Non-Small Cell Lung Carcinoma
Cisplatin
Platinum
Disease-Free Survival
23 Citations (Scopus)

Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: Outcomes of an expanded access program

Obasaju, C. K., Ye, Z., Wozniak, A. J., Belani, C. P., Keohan, M. L., Ross, H. J., Polikoff, J. A., Mintzer, D. M., Monberg, M. J. & Jänne, P. A., Feb 2007, In : Lung Cancer. 55, 2, p. 187-194 8 p.

Research output: Contribution to journalArticle

Pemetrexed
Cisplatin
Drug Therapy
Mesothelioma
Survival
2006
21 Citations (Scopus)

A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma

Ross, H. J., Hart, L. L., Swanson, P. M., Rarick, M. U., Figlin, R. A., Jacobs, A. D., McCune, D. E., Rosenberg, A. H., Baron, A. D., Grove, L. E., Thorn, M. D., Miller, D. M., Drachman, J. G. & Rudin, C. M., Oct 2006, In : Lung Cancer. 54, 1, p. 69-77 9 p.

Research output: Contribution to journalArticle

docetaxel
Immunoconjugates
Non-Small Cell Lung Carcinoma
Multicenter Studies
Safety
55 Citations (Scopus)

Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma

Chu, Y., Wang, L. X., Yang, G., Ross, H. J., Urba, W. J., Prell, R., Jooss, K., Xiong, S. & Hu, H. M., Jul 2006, In : Journal of Immunotherapy. 29, 4, p. 367-380 14 p.

Research output: Contribution to journalArticle

docetaxel
Lewis Lung Carcinoma
Cancer Vaccines
Granulocyte-Macrophage Colony-Stimulating Factor
Drug Therapy

Erratum: Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: Outcomes from a phase IIIB expanded access program (Journal of Thoracic Oncology (2006) 1, (506-512))

Jänne, P. A., Wozniak, A. J., Belani, C. P., Keohan, M. L., Ross, H. J., Polikoff, J. A., Mintzer, D. M., Ye, Z., Monberg, M. J. & Obasaju, C. K., Sep 2006, In : Journal of Thoracic Oncology. 1, 7, p. 621 1 p.

Research output: Contribution to journalArticle

Pemetrexed
Cisplatin
Thorax
Malignant Mesothelioma
24 Citations (Scopus)

Neuroendocrine-like differentiation of non-small cell lung carcinoma cells: Regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1

Walker, G. E., Antoniono, R. J., Ross, H. J., Paisley, T. E. & Oh, Y., Mar 23 2006, In : Oncogene. 25, 13, p. 1943-1954 12 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Lung Neoplasms
Cell Line
Neuroendocrine Carcinoma
Neuroendocrine Cells
54 Citations (Scopus)

Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: Outcomes from a phase IIIB expanded access program

Jänne, P. A., Wozniak, A. J., Belani, C. P., Keohan, M. L., Ross, H. J., Polikoff, J. A., Mintzer, D. M., Ye, Z., Monberg, M. J. & Obasaju, C. K., Jul 2006, In : Journal of Thoracic Oncology. 1, 6, p. 506-512 7 p.

Research output: Contribution to journalArticle

Pemetrexed
Cisplatin
Malignant Mesothelioma
Drug Therapy
Survival
137 Citations (Scopus)

Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX® vaccine in advanced-stage non-small-cell lung cancer

Nemunaitis, J., Jahan, T., Ross, H. J., Sterman, D., Richards, D., Fox, B., Jablons, D., Aimi, J., Lin, A. & Hege, K., Jun 2006, In : Cancer Gene Therapy. 13, 6, p. 555-562 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Granulocyte-Macrophage Colony-Stimulating Factor
Vaccines
Neoplasms
Genetic Transduction
3 Citations (Scopus)

Phase II trial of pemetrexed in patients with selected stage IIIB/IV bronchioloalveolar carcinoma

Ho, C., Ross, H. J. & Davies, A., Nov 2006, In : Clinical Lung Cancer. 8, 3, p. 220-222 3 p.

Research output: Contribution to journalArticle

Pemetrexed
Folate Receptor 1
Bronchiolo-Alveolar Adenocarcinoma
Folic Acid Antagonists
Epidermal Growth Factor Receptor
2005
95 Citations (Scopus)

Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim

Li, R., Moudgil, T., Ross, H. J. & Hu, H. M., Mar 2005, In : Cell Death and Differentiation. 12, 3, p. 292-303 12 p.

Research output: Contribution to journalArticle

Paclitaxel
Non-Small Cell Lung Carcinoma
Apoptosis
Cell Line
Proteins
109 Citations (Scopus)

Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: Outcomes of an expanded access program

Jänne, P. A., Wozniak, A. J., Belani, C. P., Keohan, M. L., Ross, H. J., Polikoff, J. A., Mintzer, D. M., Taylor, L., Ashland, J., Ye, Z., Monberg, M. J. & Obasaju, C. K., Jul 2005, In : Clinical Lung Cancer. 7, 1, p. 40-46 7 p.

Research output: Contribution to journalArticle

Pemetrexed
Mesothelioma
Cisplatin
Therapeutics
Drug Therapy
2004
12 Citations (Scopus)

Manipulating the host response to autologous tumour vaccines.

Ma, J., Poehlein, C. H., Jensen, S. M., LaCelle, M. G., Moudgil, T. M., Rüttinger, D., Haley, D., Goldstein, M. J., Smith, J. W., Curti, B., Ross, H. J., Walker, E., Hu, H. M., Urba, W. J. & Fox, B. A., 2004, In : Developments in Biologicals. 116

Research output: Contribution to journalArticle

Cancer Vaccines
Chemotherapy
Vaccines
Tumors
Immunology
17 Citations (Scopus)

Selective dose escalation of chemoradiotherapy for esophageal cancer: Role of treatment intensification

Seung, S. K., Smith, J. W., Molendyk, J., Bader, S. B., Phillips, M., Regan, J., Louie, J., Soo, E., Seligman, M., Ruzich, J., Skokan, L. & Ross, H. J., Dec 2004, In : Seminars in Oncology. 31, SUPPL. 18, p. 13-19 7 p.

Research output: Contribution to journalArticle

Chemoradiotherapy
Esophageal Neoplasms
Therapeutics
Carboplatin
Paclitaxel
1997
11 Citations (Scopus)

Cyclosporin A enhances paclitaxel toxicity against leukemia and respiratory epithelial cancers

Ross, H. J., Canada, A. L. & Slater, L. M., 1997, In : Clinical Cancer Research. 3, 1, p. 57-62 6 p.

Research output: Contribution to journalArticle

Paclitaxel
Cyclosporine
Leukemia
Macrophage Colony-Stimulating Factor
Multiple Drug Resistance
25 Citations (Scopus)

High and low dose rate irradiation have opposing effects on cytokine gene expression in human glioblastoma cell lines

Ross, H. J., Canada, A. L., Antoniono, R. J. & Redpath, J. L., Jan 1997, In : European Journal of Cancer Part A. 33, 1, p. 144-152 9 p.

Research output: Contribution to journalArticle

Glioblastoma
Radiation Effects
Cytokines
Interleukin-1
Gene Expression
12 Citations (Scopus)

Phase I/II trial of low dose cyclosporin a with EP for advanced non- small cell lung cancer

Ross, H. J., Cho, J., Osann, K., Wong, S. F., Ramsinghani, N., Williams, J., Downey-Hurtado, N. & Slater, L. M., Oct 1997, In : Lung Cancer. 18, 2, p. 189-198 10 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Cyclosporine
Etoposide
Cisplatin
Karnofsky Performance Status